Clin2
NCT07616544Possibly a fitNot yet recruiting

Chinese Herbal Treatment After Heart Artery Opening

Percutaneous Coronary InterventionMyocardial RevascularizationCoronary Artery Disease

Part of Heart & circulation clinical trials.

This study tests whether a Chinese herbal medicine called Qidan Xiaoke Granules can help patients recover better after a procedure to open blocked heart arteries (called PCI). The goal is to see if this herbal treatment reduces heart problems after the procedure.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
164 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are between 18 and 80 years old
  • You have been diagnosed with coronary heart disease (narrowed or blocked heart arteries)
  • You have recently had or are planning to have a PCI procedure (a catheter-based treatment to open blocked arteries)
  • Your liver and kidneys are working reasonably well
  • You are not pregnant, breastfeeding, or have severe mental health conditions that prevent clear communication
  • You do not have active bleeding, recent bleeding (within 1 month), or take blood-thinning medications like warfarin

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07493603Recruiting· Phase 1/Phase 2
Herbal medicine study for chest pain after stent placement

This trial tests a traditional Chinese herbal formula, Yiyang Huoluo Decoction, for people who still have chest discomfort after getting a stent for coronary heart disease. It aims to see if the herbal treatment can improve symptoms.

Huzhou, Zhejiang
NCT07613060Not yet recruiting
Chinese Medicine Heart Disease Outcomes Study

This study looks at patterns in heart disease outcomes after bypass or stent surgery, using traditional Chinese medicine principles to predict how patients will do long-term. Researchers hope to identify which patients are at higher risk for complications so they can plan better care.

NCT06399692Recruiting· Phase 3
Heart treatment study for women with blocked arteries

This trial is comparing two common heart procedures—bypass surgery (CABG) and stents (PCI)—to see which works better for women with blockages in multiple heart arteries. It aims to find the best treatment for women, who are often underrepresented in heart research.

Glendale, California
NCT07607951Not yet recruiting
Baduanjin Exercise Program After Heart Stent Placement

This study tests whether Baduanjin—a gentle, traditional Chinese movement exercise—helps people recover better after coronary stent placement (a procedure to open blocked heart arteries). Researchers want to see if this exercise improves heart health and quality of life.

NCT07621107Not yet recruiting· Phase 2
Chinese herbal medicine for heart blood flow after heart attack

This trial tests whether Guanxinning Tablet, a Chinese herbal medicine, can improve blood flow in the tiny vessels of the heart after an acute heart attack (STEMI) treated with emergency angioplasty. The study measures heart function changes over 6 months using imaging.

NCT07041359Recruiting· Phase 4
Traditional Chinese medicine for elderly heart disease patients with ongoing symptoms

This trial tests whether traditional Chinese medicine can help elderly patients with coronary heart disease who still have chest pain or discomfort despite standard treatments. It focuses on those who cannot have or have not fully benefited from procedures like stents or bypass surgery.

Beijing, Beijing Municipality

Hear when a new Percutaneous Coronary Intervention trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.